SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-034343
Filing Date
2019-09-09
Accepted
2019-09-09 14:07:39
Documents
10
Period of Report
2019-09-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K insy-8k_20190906.htm 8-K 43770
2 EX-99.1 insy-ex991_6.htm EX-99.1 128346
3 GRAPHIC gypx14qwe2cv000004.jpg GRAPHIC 19072
4 GRAPHIC gypx14qwe2cv000005.jpg GRAPHIC 59672
5 GRAPHIC gypx14qwe2cv000006.jpg GRAPHIC 107622
6 GRAPHIC gypx14qwe2cv000003.jpg GRAPHIC 67024
7 GRAPHIC gypx14qwe2cv000008.jpg GRAPHIC 16377
8 GRAPHIC gypx14qwe2cv000001.jpg GRAPHIC 10404
9 GRAPHIC gypx14qwe2cv000007.jpg GRAPHIC 11905
10 GRAPHIC gypx14qwe2cv000002.jpg GRAPHIC 69118
  Complete submission text file 0001564590-19-034343.txt   671831
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35902 | Film No.: 191082841
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1